Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Canadian Journal of Diabetes is Scopus-indexed (Q2, CiteScore 4.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 1499-2671Verify ISSN ↗2352-3840Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$3,300 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 64 / 179 | 64th | Q2 |
| Endocrinology, Diabetes and Metabolism | 114 / 250 | 54th | Q2 |
| Endocrinology | 73 / 132 | 45th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q2, CiteScore 4.7.
Canadian Journal of Diabetes is Q2 in Internal Medicine (rank 64 of 179), Q2 in Endocrinology, Diabetes and Metabolism (rank 114 of 250) and Q3 in Endocrinology (rank 73 of 132), by CiteScore 2025.
Canadian Journal of Diabetes is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.7, which places it in quartile Q2 at the 64th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.956, quartile Q1, with an H-index of 63.
The publisher lists an article processing charge of about US$3,300 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Canadian Journal of Diabetes is published by Elsevier B.V. Its print ISSN is 1499-2671 and its online ISSN is 2352-3840.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Canadian Journal of Diabetes has an h-index of 78 and a 2-year mean of 0.7 citations per paper (OpenAlex). Its Scopus CiteScore is 4.7, quartile Q2. On 2-year citations it ranks #119 of 172 Scopus journals in Internal Medicine.
Canadian Journal of Diabetes published 282 papers in 2025; its busiest recent year was 2023 with 498. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2025–2026), authors are most often from Canada (60.1%), China (9.8%) and United States (8.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 14 retracted papers are recorded (2.1 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.